Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomized trial comparing Bangerter filters and patching for the treatment of moderate amblyopia in children.
Pediatric Eye Disease Investigator Group Writing Committee; Rutstein RP, Quinn GE, Lazar EL, Beck RW, Bonsall DJ, Cotter SA, Crouch ER, Holmes JM, Hoover DL, Leske DA, Lorenzana IJ, Repka MX, Suh DW. Pediatric Eye Disease Investigator Group Writing Committee, et al. Among authors: rutstein rp. Ophthalmology. 2010 May;117(5):998-1004.e6. doi: 10.1016/j.ophtha.2009.10.014. Epub 2010 Feb 16. Ophthalmology. 2010. PMID: 20163869 Free PMC article. Clinical Trial.
Patching vs atropine to treat amblyopia in children aged 7 to 12 years: a randomized trial.
Scheiman MM, Hertle RW, Kraker RT, Beck RW, Birch EE, Felius J, Holmes JM, Kundart J, Morrison DG, Repka MX, Tamkins SM; Pediatric Eye Disease Investigator Group. Scheiman MM, et al. Arch Ophthalmol. 2008 Dec;126(12):1634-42. doi: 10.1001/archophthalmol.2008.107. Arch Ophthalmol. 2008. PMID: 19064841 Free PMC article. Clinical Trial.
A randomized trial of atropine vs patching for treatment of moderate amblyopia: follow-up at age 10 years.
Pediatric Eye Disease Investigator Group; Repka MX, Kraker RT, Beck RW, Holmes JM, Cotter SA, Birch EE, Astle WF, Chandler DL, Felius J, Arnold RW, Tien DR, Glaser SR. Pediatric Eye Disease Investigator Group, et al. Arch Ophthalmol. 2008 Aug;126(8):1039-44. doi: 10.1001/archopht.126.8.1039. Arch Ophthalmol. 2008. PMID: 18695096 Free PMC article. Clinical Trial.
Pilot study of levodopa dose as treatment for residual amblyopia in children aged 8 years to younger than 18 years.
Repka MX, Kraker RT, Beck RW, Atkinson CS, Bacal DA, Bremer DL, Davis PL, Gearinger MD, Glaser SR, Hoover DL, Laby DM, Morrison DG, Rogers DL, Sala NA, Suh DW, Wheeler MB; Pediatric Eye Disease Investigator Group. Repka MX, et al. Arch Ophthalmol. 2010 Sep;128(9):1215-7. doi: 10.1001/archophthalmol.2010.178. Arch Ophthalmol. 2010. PMID: 20837811 Free PMC article. Clinical Trial. No abstract available.
Randomized trial to evaluate combined patching and atropine for residual amblyopia.
Pediatric Eye Disease Investigator Group (PEDIG) Writing Committee; Wallace DK, Kraker RT, Beck RW, Cotter SA, Davis PL, Holmes JM, Repka MX, Suh DW. Pediatric Eye Disease Investigator Group (PEDIG) Writing Committee, et al. Arch Ophthalmol. 2011 Jul;129(7):960-2. doi: 10.1001/archophthalmol.2011.174. Arch Ophthalmol. 2011. PMID: 21746992 Free PMC article. Clinical Trial. No abstract available.
Progressive-addition lenses versus single-vision lenses for slowing progression of myopia in children with high accommodative lag and near esophoria.
Correction of Myopia Evaluation Trial 2 Study Group for the Pediatric Eye Disease Investigator Group. Correction of Myopia Evaluation Trial 2 Study Group for the Pediatric Eye Disease Investigator Group. Invest Ophthalmol Vis Sci. 2011 Apr 25;52(5):2749-57. doi: 10.1167/iovs.10-6631. Invest Ophthalmol Vis Sci. 2011. PMID: 21282579 Free PMC article. Clinical Trial.
Efficacy and stability of amblyopia therapy.
Rutstein RP, Fuhr PS. Rutstein RP, et al. Optom Vis Sci. 1992 Oct;69(10):747-54. doi: 10.1097/00006324-199210000-00001. Optom Vis Sci. 1992. PMID: 1436994
89 results